Is Ketamine Therapy Safe? An Honest Assessment

When patients ask me "is ketamine safe?" I give them the same answer I give about any medication: safe compared to what? For whom? At what dose? Under what supervision?

The honest answer is more nuanced than either the enthusiasts or the critics would have you believe. Ketamine is neither the risk-free miracle some online providers imply, nor the dangerous drug of abuse some skeptics suggest. It's a medication with a well-characterized safety profile, real benefits for specific conditions, and risks that need to be understood and managed.

Here's my honest assessment.

The Safety Data We Have

Ketamine has been used in medicine since 1970. That's over 55 years of clinical use — first as an anesthetic, then in emergency medicine, and more recently for depression and chronic pain. This gives us an unusually long track record compared to newer psychiatric medications.

As an anesthetic: Ketamine is considered one of the safest anesthetics available. It's used in pediatric surgery, emergency medicine, and battlefield medicine precisely because it maintains airway reflexes and has a wide therapeutic window (the gap between an effective dose and a dangerous dose). This wide safety margin is one reason it was attractive for psychiatric use.

For depression: The evidence base for ketamine in depression spans over two decades of clinical trials. The FDA approved esketamine (Spravato) in 2019 after extensive safety review. Post-marketing surveillance data continues to accumulate. No unexpected safety signals have emerged.

In clinical practice: Thousands of patients have received ketamine therapy through infusion clinics and telehealth providers. Published safety data from these settings shows a low incidence of serious adverse events when patients are properly screened and monitored.

Real Risks — Let's Be Specific

Cardiovascular Effects

Ketamine transiently increases blood pressure and heart rate. In most patients, this is mild (10-20 mmHg systolic) and resolves within 1-2 hours. For healthy patients, this is clinically insignificant.

Who it matters for: Patients with uncontrolled hypertension, unstable angina, recent heart attack, aortic dissection, or decompensated heart failure. These patients should either avoid ketamine or undergo treatment only with continuous monitoring in a clinical setting.

Mitigation: Blood pressure screening before starting treatment. Home blood pressure monitoring for patients on at-home protocols. Dose adjustment or discontinuation if blood pressure responses are excessive.

Dissociative and Psychological Effects

Ketamine produces dissociation — a feeling of detachment from your body and surroundings. For most patients, this is neutral to mildly pleasant. For some, it can be distressing, particularly if unexpected.

Who it matters for: Patients with a history of psychosis or schizophrenia — ketamine can potentially exacerbate psychotic symptoms. Patients with severe anxiety about loss of control may find dissociation very uncomfortable.

Mitigation: Thorough psychiatric screening. Setting appropriate expectations before the first session. Starting at low doses and titrating up. Having a sitter present for initial sessions.

Nausea

Nausea is one of the most common side effects, affecting roughly 10-20% of patients with sublingual dosing. It's usually mild and manageable.

Mitigation: Avoiding eating for 2-3 hours before a session. Anti-nausea medication (ondansetron) if needed. Ginger supplements. Dose adjustment.

Urinary Tract Effects

This is the risk that deserves the most careful discussion because it's the one that distinguishes therapeutic use from abuse.

Chronic ketamine abuse — daily, high-dose, recreational use — is well-documented to cause severe bladder damage (ketamine cystitis). This includes frequency, urgency, pain, and in severe cases, bladder contracture requiring surgical intervention.

The critical context: These effects are seen in recreational users consuming vastly higher quantities than therapeutic doses, typically daily, for months to years. A recreational ketamine user might consume 1-5 grams per day. A therapeutic dose is typically 100-300 mg taken 2-3 times per week at most.

In therapeutic use: Published data from clinical ketamine programs has not shown significant urinary tract effects at therapeutic doses and frequencies. However, long-term data (10+ years of continuous therapeutic use) is limited. This is an area that deserves ongoing monitoring.

Mitigation: Using the lowest effective dose. Monitoring for urinary symptoms at every follow-up. Reducing frequency if symptoms emerge. Staying well-hydrated.

Abuse and Dependence Potential

Ketamine is a Schedule III controlled substance. It has abuse potential, and psychological dependence can develop, particularly in patients with a history of substance use disorder.

The nuance: Abuse potential in a therapeutic context is different from street-level abuse potential. Patients using ketamine under medical supervision, at prescribed doses, on a defined schedule, rarely develop problematic use patterns. The structure of the therapeutic relationship provides built-in safeguards.

Who it matters for: Patients with active substance use disorder, particularly with stimulants or dissociatives. Patients with a history of substance abuse need careful evaluation — a history of substance use disorder doesn't automatically disqualify someone, but it requires heightened caution and monitoring.

Mitigation: Thorough substance use screening. Limited quantities prescribed at a time. Regular follow-up with specific attention to patterns of use. Clear expectations about dosing frequency.

Cognitive Effects

Chronic recreational ketamine use is associated with cognitive impairment, particularly in memory. In therapeutic use at standard doses, significant cognitive impairment has not been consistently demonstrated, though some patients report transient brain fog after sessions.

Mitigation: Using the lowest effective dose. Monitoring cognitive function. Spacing sessions appropriately.

Who Should NOT Use Ketamine

Based on current evidence, ketamine therapy is contraindicated or requires extreme caution in:

• Active psychosis or schizophrenia — risk of exacerbating symptoms
• Uncontrolled hypertension — cardiovascular risk
• Unstable cardiovascular disease — same
• Active substance use disorder with stimulants or dissociatives
• Pregnancy — insufficient safety data
• History of intracranial hypertension — ketamine can raise intracranial pressure
• Severe liver disease — ketamine is hepatically metabolized

These aren't guidelines I bend. Proper screening isn't bureaucratic caution — it's how you keep patients safe.

How to Maximize Safety

If you're considering ketamine therapy, here's how to ensure you're doing it as safely as possible:

Choose a thorough provider. The evaluation should take time. If someone prescribes ketamine after a 5-minute online questionnaire, they're not practicing safely. A proper evaluation includes medical history, psychiatric history, medication review, substance use screening, and a discussion of risks and benefits.

Follow the protocol. Take the prescribed dose at the prescribed frequency. Don't double up because you had a rough week. Don't take extra because you're curious what a higher dose feels like. This is medication, not recreation.

Have a sitter. Especially for initial sessions. Someone who can help you if you feel distressed, make sure you don't fall, and keep you from doing anything impaired (like driving).

Report symptoms. If you notice increased urinary frequency, difficulty urinating, new cognitive issues, or a desire to take ketamine outside the prescribed schedule — tell your doctor immediately.

Keep follow-up appointments. Regular monitoring is how adverse effects get caught early. Skipping follow-ups increases risk.

My Bottom Line

Ketamine therapy is safe for appropriately selected and monitored patients. It is not risk-free — no medication is. The risks are real but manageable with proper screening, dosing, and follow-up.

The biggest safety risk in ketamine therapy isn't the drug itself — it's inadequate provider oversight. A well-screened patient, taking a proper dose under physician supervision with regular follow-up, faces a favorable risk-benefit profile. A poorly screened patient, taking unmonitored doses without follow-up, faces real and avoidable risks.

At Coral Health, safety is not optional. Every ketamine patient undergoes comprehensive evaluation, receives clear protocols, and has regular follow-up built into their treatment plan. That's the minimum standard, and it shouldn't be negotiable regardless of where you receive treatment.

If you're considering ketamine therapy, ask your provider about their screening process, monitoring protocols, and what happens if you experience side effects. Their answers will tell you whether you're in good hands.